ITK Inhibitors in Inflammation and Immune-Mediated Disorders

Author(s): Nisebita Sahu, Avery August.

Journal Name: Current Topics in Medicinal Chemistry

Volume 9 , Issue 8 , 2009

Become EABM
Become Reviewer

Abstract:

Interleukin-2-inducible T cell kinase (ITK) is a non-receptor tyrosine kinase expressed in T cells, NKT cells and mast cells which plays a crucial role in regulating the T cell receptor (TCR), CD28, CD2, chemokine receptor CXCR4, and FcηR-mediated signaling pathways. In T cells, ITK is an important mediator for actin reorganization, activation of PLCγ, mobilization of calcium, and activation of the NFAT transcription factor. ITK plays an important role in the secretion of IL-2, but more critically, also has a pivotal role in the secretion of Th2 cytokines, IL-4, IL-5 and IL-13. As such, ITK has been shown to regulate the development of effective Th2 response during allergic asthma as well as infections by parasitic worms. This ability of ITK to regulate Th2 responses, along with its pattern of expression, has led to the proposal that it would represent an excellent target for Th2-mediated inflammation. We discuss here the possibilities and pitfalls of targeting ITK for inflammatory disorders.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 9
ISSUE: 8
Year: 2009
Page: [690 - 703]
Pages: 14
DOI: 10.2174/156802609789044443
Price: $58

Article Metrics

PDF: 17